Unity Biotechnology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch UBX and buy or sell other stocks, ETFs, and their options commission-free!About UBX
Unity Biotechnology, Inc. operates as a biotechnology company. The firm is developing a portfolio of programs like biological mechanisms implicated in diseases of aging, and also senolytic programs in ophthalmologic and neurologic disorders.
CEOCraig R. Jalbert
CEOCraig R. Jalbert
Employees16
Employees16
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2009
Founded2009
Employees16
Employees16
UBX Key Statistics
Market cap29.78M
Market cap29.78M
Price-Earnings ratio-0.03
Price-Earnings ratio-0.03
Dividend yield—
Dividend yield—
Average volume54.60K
Average volume54.60K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.10
52 Week high$3.10
52 Week low$0.0487
52 Week low$0.0487
Stock Snapshot
Unity Biotechnology(UBX) stock is priced at $1.73, giving the company a market capitalization of 29.78M. It carries a P/E multiple of -0.03.
Unity Biotechnology(UBX) stock opened on 2026-01-02 at —. The price climbed to — and dipped to —.
The Unity Biotechnology(UBX)'s current trading volume is 0, compared to an average daily volume of 54.6K.
In the last year, Unity Biotechnology(UBX) shares hit a 52-week high of $3.10 and a 52-week low of $0.05.
In the last year, Unity Biotechnology(UBX) shares hit a 52-week high of $3.10 and a 52-week low of $0.05.
People also own
Based on the portfolios of people who own UBX. This list is generated using Robinhood data, and it’s not a recommendation.